Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal–fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis

PURPOSE: To determine the frequency of fetal infection as well as adverse pregnancy outcomes following antenatal hyperimmunoglobulin (HIG) treatment for primary cytomegalovirus (CMV) infection in pregnancy. METHODS: In our observational cohort study, data from 46 women with a primary CMV infection d...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidel, Vera, Hackelöer, Max, Rancourt, Rebecca C., Henrich, Wolfgang, Siedentopf, Jan-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Maternal-Fetal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584525/
https://www.ncbi.nlm.nih.gov/pubmed/32754858
http://dx.doi.org/10.1007/s00404-020-05728-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584525/
https://www.ncbi.nlm.nih.gov/pubmed/32754858
http://dx.doi.org/10.1007/s00404-020-05728-7

Ejemplares similares